Recent publications · Crossref
5 total works indexed
- Olaparib for Metastatic Breast Cancer in Patients with a Germline
<i>BRCA</i>
Mutation
· 2017 · cited 2,842x
- 2023 ESC Guidelines for the management of cardiomyopathies
· 2023 · cited 2,271x
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
· 2012 · cited 2,004x
- Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer